Vital Signs - The Economics of Mainstream Virtual Colonoscopy


USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

This issue of Vital Signs, released on November 10, 2008, provides an strategic overview of the economics in mainstream use of virtual colonoscopy. Additionally, a company spotlight is provided for Rendoscopy, a provider of advanced 3D software tools for 3D visualization and data analysis. Reimbursement and regulatory news from the FDA is also provided for the week of October 27, 2008.

Table of Contents

Vital Signs - The Economics of Mainstream Virtual ColonoscopyVital Signs: 10 November 2008This week's issue:

Related Research

Release Date : 21-Nov-18

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.